{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:15:32Z","timestamp":1788498932638,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","award":["88887.187259\/2025-00"],"award-info":[{"award-number":["88887.187259\/2025-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbr.2026.116429","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:02:52Z","timestamp":1786633372000},"page":"116429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ibogaine as a double-edged sword: Developmental cardiotoxicity and neurobehavioral alterations in zebrafish"],"prefix":"10.1016","volume":"515","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-0546","authenticated-orcid":false,"given":"Arthur L.","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia R.","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Guimar\u00e3es","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Eduardo Cec\u00edlio","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Palma","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/15672050113109990001","article-title":"Ibogaine in the treatment of substance dependence","volume":"6","author":"Brown","year":"2013","journal-title":"Curr. Drug. Abus. Rev."},{"key":"10.1016\/j.bbr.2026.116429_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108717","article-title":"A systematic literature review of clinical trials and therapeutic applications of ibogaine","volume":"138","author":"K\u00f6ck","year":"2022","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.bbr.2026.116429_bib3","first-page":"1","article-title":"A review","volume":"56","author":"Ibogaine","year":"2001","journal-title":"Alkaloid. Chem. Biol."},{"issue":"11","key":"10.1016\/j.bbr.2026.116429_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/0269881114552713","article-title":"Treating drug dependence with the aid of ibogaine: A retrospective study","volume":"28","author":"Schenberg","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2026.116429_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0091-3057(95)00152-M","article-title":"Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats","volume":"52","author":"Rezvani","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.bbr.2026.116429_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.71","article-title":"Ibogaine and addiction in the animal model, a systematic review and meta-analysis","volume":"6","author":"Belgers","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/molecules20022208","article-title":"The anti-addiction drug ibogaine and the heart: a delicate relation","volume":"20","author":"Koenig","year":"2015","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1556-4029.2011.02008.x","article-title":"Fatalities temporally associated with the ingestion of ibogaine","volume":"57","author":"Alper","year":"2012","journal-title":"J. Forensic Sci."},{"issue":"6","key":"10.1016\/j.bbr.2026.116429_bib9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00213-021-05964-y","article-title":"The adverse events of ibogaine in humans: an updated systematic review of the literature (2015-2020)","volume":"239","author":"Ona","year":"2022","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib10","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1038\/s41467-024-51856-y","article-title":"Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models","volume":"15","author":"Havel","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbr.2026.116429_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0960327107087802","article-title":"V. Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review","volume":"27","author":"Kontrimaviciute","year":"2008","journal-title":"Human. Exp. Toxicol."},{"issue":"5","key":"10.1016\/j.bbr.2026.116429_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/02698811241237873","article-title":"The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients","volume":"38","author":"Knuijver","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.bbr.2026.116429_bib13","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell. Rep."},{"key":"10.1016\/j.bbr.2026.116429_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphar.2019.00193","article-title":"Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits","volume":"10","author":"Marton","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41591-023-02705-w","article-title":"Magnesium-ibogaine therapy in veterans with traumatic brain injuries","volume":"30","author":"Cherian","year":"2024","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bbr.2026.116429_bib16","first-page":"680","article-title":"Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20\u2009mg dose of ibogaine in healthy volunteers. Journal of Clinical Pharmacology","volume":"55","author":"Glue","year":"2015"},{"key":"10.1016\/j.bbr.2026.116429_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106620","article-title":"IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy","volume":"190","author":"Mash","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbr.2026.116429_bib18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1749-6632.2000.tb05213.x","article-title":"Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures","volume":"914","author":"Mash","year":"2000","journal-title":"Ann. New. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.bbr.2026.116429_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jat\/19.6.427","article-title":"Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry","volume":"19","author":"Hearn","year":"1995","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.bbr.2026.116429_bib20","doi-asserted-by":"crossref","first-page":"PL119","DOI":"10.1016\/0024-3205(95)02322-4","article-title":"Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration","volume":"58","author":"Hough","year":"1996","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.bbr.2026.116429_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/0269881116641331","article-title":"Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents","volume":"30","author":"Mash","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/add.15448","article-title":"Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study","volume":"117","author":"Knuijver","year":"2022","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1369-1600.2012.00447.x","article-title":"Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk","volume":"19","author":"Koenig","year":"2014","journal-title":"Addict. Biol."},{"issue":"7446","key":"10.1016\/j.bbr.2026.116429_bib24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bbr.2026.116429_bib25","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.3390\/ijms23126647","article-title":"Zebrafish larvae behavior models as a tool for drug screenings and pre-clinical trials: A review","volume":"23","author":"Rosa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2026.116429_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.taap.2003.07.012","article-title":"Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia","volume":"193","author":"Langheinrich","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbr.2026.116429_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.624129","article-title":"Utility of zebrafish models of acquired and inherited long QT syndrome","volume":"11","author":"Simpson","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbr.2026.116429_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beproc.2018.01.020","article-title":"Extending the analysis of zebrafish behavioral endophenotypes for modeling psychiatric disorders: Fear conditioning to conspecific alarm response","volume":"149","author":"Maximino","year":"2018","journal-title":"Behav. Process."},{"issue":"4","key":"10.1016\/j.bbr.2026.116429_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/zeb.2010.0669","article-title":"A review of monoaminergic neuropsychopharmacology in zebrafish","volume":"7","author":"Maximino","year":"2010","journal-title":"Zebrafish"},{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/zeb.2012.0861","article-title":"Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond","volume":"10","author":"Kalueff","year":"2013","journal-title":"Zebrafish"},{"key":"10.1016\/j.bbr.2026.116429_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuro.2023.04.009","article-title":"Long-term behavioral alterations following embryonic alcohol exposure in three zebrafish populations","volume":"96","author":"Agues-Barbosa","year":"2023","journal-title":"Neurotoxicology"},{"issue":"10","key":"10.1016\/j.bbr.2026.116429_bib32","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3390\/biomedicines10102555","article-title":"Ethanol Effects on Early Developmental Stages Studied Using the Zebrafish","volume":"10","author":"Manikandan","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.bbr.2026.116429_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/toxics10090544","article-title":"Effect of embryonic alcohol exposure on craniofacial and skin melanocyte development: Insights from zebrafish (Danio rerio)","volume":"10","author":"Azimian Zavareh","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.bbr.2026.116429_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuro.2021.11.001","article-title":"Developmental exposure to MDMA (ecstasy) in zebrafish embryos reproduces the neurotoxicity adverse outcome 'lower motor activity' described in humans","volume":"88","author":"Barenys","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2026.116429_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fnbeh.2018.00190","article-title":"It's tea time: Interference of ayahuasca brew on discriminative learning in zebrafish","volume":"12","author":"Lobao-Soares","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2026.116429_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fnbeh.2017.00139","article-title":"Behavioral changes over time following ayahuasca exposure in zebrafish","volume":"11","author":"Savoldi","year":"2017","journal-title":"Front. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2026.116429_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1021\/acschemneuro.2c00642","article-title":"Developmental neurotoxicity screen of psychedelics and other drugs of abuse in larval zebrafish (Danio rerio)","volume":"14","author":"Tombari","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2026.116429_bib38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41380-023-02391-7","article-title":"High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin","volume":"29","author":"Braun","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbr.2012.08.041","article-title":"Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research","volume":"236","author":"Cachat","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"15","key":"10.1016\/j.bbr.2026.116429_bib40","article-title":"Zebrafish early life stages as alternative model to study 'designer drugs': Concordance with mammals in response to opioids","volume":"419","author":"Kirla","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2007.09.086","article-title":"Developmental expression and distribution of opioid receptors in zebrafish","volume":"151","author":"Sanchez-Simon","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2026.116429_bib42","series-title":"OECD Guidelines for the Testing of Chemicals, Section 2","article-title":"Test No. 236: Fish Embryo Acute Toxicity (FET) Test","author":"OECD","year":"2025"},{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib43","first-page":"38","article-title":"DarT: The embryo test with the zebrafish Danio rerio - a general model in ecotoxicology and toxicology","volume":"19","author":"Nagel","year":"2002","journal-title":"ALTEX"},{"issue":"3","key":"10.1016\/j.bbr.2026.116429_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the zebrafish","volume":"203","author":"Kimmel","year":"1995","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbr.2026.116429_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.139894","article-title":"Integrating morphological, biochemical, behavioural, and molecular approaches to investigate developmental toxicity triggered by tebuthiuron in zebrafish (Danio rerio)","volume":"340","author":"de Oliveira","year":"2023","journal-title":"Chemosphere"},{"issue":"15","key":"10.1016\/j.bbr.2026.116429_bib46","article-title":"Zebrafish (Danio rerio) embryo-larvae locomotor activity data analysis: Evaluating anxiolytic effects of the antidepressant compound citalopram","volume":"27","author":"Pohl","year":"2019","journal-title":"Data Brief."},{"key":"10.1016\/j.bbr.2026.116429_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.aquatox.2015.09.011","article-title":"Age matters: Developmental stage of Danio rerio larvae influences photomotor response thresholds to diazinion or diphenhydramine","volume":"170","author":"Kristofco","year":"2016","journal-title":"Aquat. Toxicol."},{"issue":"1","key":"10.1016\/j.bbr.2026.116429_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuro.2008.09.011","article-title":"Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol","volume":"30","author":"MacPhail","year":"2009","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbr.2011.12.016","article-title":"Measuring thigmotaxis in larval zebrafish","volume":"228","author":"Schn\u00f6rr","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.bbr.2026.116429_bib50","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/acschemneuro.8b00294","article-title":"DARK classics in chemical neuroscience: Ibogaine","volume":"9","author":"Wasko","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbr.2026.116429_bib51","article-title":"Optimization of the spontaneous tail coiling test for fast assessment of neurotoxic effects in the zebrafish embryo using an automated workflow in KNIME\u00ae","volume":"81","author":"Ogungbemi","year":"2020","journal-title":"Neurotoxicology Teratol."},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/w13020119","article-title":"Tail coiling assay in zebrafish (Danio rerio) embryos: Stage of development, promising positive control candidates, and selection of an appropriate organic solvent for screening of developmental neurotoxicity (DNT)","volume":"13","author":"de Oliveira","year":"2021","journal-title":"Water"},{"key":"10.1016\/j.bbr.2026.116429_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/toxics10090493","article-title":"Embryonic arsenic exposure triggers long-term behavioral impairment with metabolite alterations in zebrafish","volume":"10","author":"Abu Bakar","year":"2022","journal-title":"Toxics"},{"issue":"30","key":"10.1016\/j.bbr.2026.116429_bib54","doi-asserted-by":"crossref","first-page":"75281","DOI":"10.1007\/s11356-023-27662-2","article-title":"The sensitivity of the zebrafish embryo coiling assay for the detection of neurotoxicity by compounds with diverse modes of action","volume":"30","author":"von Hellfeld","year":"2023","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib55","article-title":"Modeling spinal locomotor circuits for movements in developing zebrafish","volume":"10","author":"Roussel","year":"2021","journal-title":"Elife"},{"issue":"20","key":"10.1016\/j.bbr.2026.116429_bib56","article-title":"Deleterious effects of benzotriazoles on zebrafish development and neurotransmission: 5-Chloro-benzotriazole versus 1H-benzotriazole","volume":"912","author":"Sampaio","year":"2024","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.bbr.2026.116429_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ntt.2013.01.003","article-title":"Assessment of the developmental neurotoxicity of compounds by measuring locomotor activity in zebrafish embryos and larvae","volume":"37","author":"Selderslaghs","year":"2013","journal-title":"Neurotoxicology Teratol."},{"issue":"13","key":"10.1016\/j.bbr.2026.116429_bib58","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3390\/nu16131997","article-title":"The study of myo-inositol's anxiolytic activity on zebrafish (Danio rerio)","volume":"16","author":"Derkaczew","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bbr.2026.116429_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2019.124587","article-title":"Behavioral effects of citalopram, tramadol, and binary mixture in zebrafish (Danio rerio) larvae","volume":"238","author":"Bachour","year":"2020","journal-title":"Chemosphere"},{"key":"10.1016\/j.bbr.2026.116429_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112625","article-title":"Rapid well-plate assays for motor and social behaviors in larval zebrafish","volume":"391","author":"Shen","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2026.116429_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbr.2017.05.008","article-title":"Anxiolytic-like effects of noribogaine in zebrafish","volume":"330","author":"Kalueff","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2026.116429_bib62","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/1471-2164-11-643","article-title":"Identification and developmental expression of the full complement of Cytochrome P450 genes in zebrafish","volume":"11","author":"Goldstone","year":"2010","journal-title":"BMC Genom."},{"key":"10.1016\/j.bbr.2026.116429_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11419-020-00543-w","article-title":"Metabolism of synthetic cathinones through the zebrafish water tank model: a promising tool for forensic toxicology laboratories","volume":"39","author":"Prado","year":"2021","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.bbr.2026.116429_bib64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tiv.2017.05.009","article-title":"vitro CYP-mediated drug metabolism in the zebrafish (embryo) using human reference compounds","volume":"42","author":"Saad","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.bbr.2026.116429_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fphar.2018.00529","article-title":"Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes","volume":"9","author":"Mash","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2026.116429_bib66","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/0269881115584461","article-title":"Noribogaine reduces nicotine self-administration in rats","volume":"29","author":"Chang","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuroscience.2006.09.028","article-title":"Identification of dynorphin a from zebrafish: a comparative study with mammalian dynorphin A","volume":"144","author":"Gonzalez-Nu\u00f1ez","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2026.116429_bib68","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuropharm.2015.08.032","article-title":"Noribogaine is a G-protein biased \u03ba-opioid receptor agonist","volume":"99","author":"Maillet","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2026.116429_bib69","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0006-8993(95)01563-9","article-title":"Ibogaine-like effects of noribogaine in rats","volume":"713","author":"Glick","year":"1996","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2026.116429_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/psymed.2023.0009","article-title":"Tabernanthalog reduces motivation for heroin and alcohol in a polydrug use model","volume":"1","author":"Heinsbroek","year":"2023","journal-title":"Psychedelic Med. (New. Rochelle)"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826004055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826004055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:25:06Z","timestamp":1788495906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432826004055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":70,"alternative-id":["S0166432826004055"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116429","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibogaine as a double-edged sword: Developmental cardiotoxicity and neurobehavioral alterations in zebrafish","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116429"}}